PEPTIDES 2017*
Chairs: Max Cryle & Jim Olson
PTG-100, an oral peptide antagonist of α4β7 integrin, for the treatment of inflammatory bowel disease (#63)
4:00 PM
Constrained and biased 11 amino acid glucagon-like peptide-1 receptor agonists (#64)
4:25 PM
Moving peptides to the clinic: improving properties to treat patients (#65)
4:50 PM
Development of a potent D-protein inhibitor of VEGF-A with reduced immunogenicity and a longer half-life (#66)
5:15 PM
Guanylate Cyclase C: A Target for the Treatment of Functional Intestinal Disorders (#67)
5:40 PM